Skip to main content

Advertisement

Log in

Influence of physical factors on tablet splitting, weight and content uniformity of atenolol tablets

  • Research Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Tablet splitting is widely practiced worldwide. Several studies have considered weight variation of split tablets as a mean of estimating drug content uniformity but the analysis of their drug content and physical factors that may affect splitting are limited. The aim of this study is to evaluate the impact of manufacturing parameters and splitting on content and weight uniformity of atenolol tablets. Atenolol tablets (100 and 50 mg) were prepared under the same manufacturing conditions and using the same excipients. The obtained tablets were checked for hardness, weight, and disintegration. The weight and the content of the two strength atenolol tablets after splitting into two halves were evaluated. Atenolol tablets (100 mg) showed higher values of hardness, disintegration time and diameter than atenolol tablets (50 mg). Atenolol tablets (100 mg) passed both weight and content uniformity while atenolol tablets (50 mg) failed these tests. Half tablet weight appears to be directly correlated with its drug content. Manufacturers should investigate physical factors such as tablet hardness, diameter, and disintegration time that may play an important role in achieving both weight and content uniformity in the resultant tablet halves.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Cook TJ, Edwards S, Gyemah C, Shah M, Shah I, Fox T (2004) Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. Am Pharm Assoc (2003) 44:583–586

    Google Scholar 

  • Duncan MC, Castle SS, Streetman DS (2002) Effect of tablet splitting on serum cholesterol concentrations. Ann Pharmacother 36:205–209

    Article  PubMed  CAS  Google Scholar 

  • Emilien G, Maloteaux JM (1998) Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol 53:389–404

    Article  PubMed  CAS  Google Scholar 

  • European Pharmacopoeia (2002) Suppl 4.1, Council of Europe; European Directorate for the Quality of Medicine, Strasbourg, Tablets Monograph 0478

  • European Pharmacopoeia (2008) Suppl 6.4, Council of Europe; European Directorate for the Quality of Medicine, Strasbourg, Tablets Monograph 0478

  • Fawell NG, Cookson TL, Scranton SS (1999) Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm 56:2542–2545

    PubMed  CAS  Google Scholar 

  • Gee M, Hasson NK, Hahn T, Ryono R (2002) Effects of a tablet-splitting program in patients taking HMG-Co A reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Managed Care Pharm 8:453–458

    Google Scholar 

  • Green G, Berg C, Polli J, Barends D (2009) Pharmacopeial standards for the subdivision characteristics of scored tablets. Pharmacopeial Forum 35:1598–1603

    Google Scholar 

  • Hill SW, Varker AS, Karlage K, Myrdal PB (2009) Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm 15:253–261

    PubMed  Google Scholar 

  • Katori N, Aoyagi N, Kojima S (2001) The study of the applicability of content uniformity and weight variation test- the state of commercial tablets and capsules in Japan. Chem Pharm Bull 49:1412–1419

    Article  PubMed  CAS  Google Scholar 

  • Kristensen HG, Jorgensen GH, Moller-Sonnergaard JJ (1995) Mass uniformity of tablets broken by hand. Pharmeuropa 7:298–302

    Google Scholar 

  • Polli JE, Kim S, Martin BR (2003) Weight uniformity of split tablets required by a Veterans Affairs policy. J Manag Care Pharm 9:401–407

    PubMed  Google Scholar 

  • Rindone JP (2000) Evaluation of tablet-splitting in patients taking lisinopril for hypertension. J Clin Outcomes Manage 7:22–24

    Google Scholar 

  • Teng J, Song CK, Williams RL, Polli JE (2002) Lack of medication dose uniformity in commonly split tablets. J Am Pharm Assoc (Wash) 42:195–199

    Google Scholar 

  • United States Pharmacopeial Convention (eds) (2005) The United States Pharmacopeia, 29th Rev., and the National Formulary, 24th edn. Rockville, p 212

  • Van Santen E, Barends DM, Frijlink HW (2002) Breaking of scored tablets: a review. Eur J Pharm Biopharm 53:139–145

    Article  PubMed  Google Scholar 

  • Vranić E, Uzunović A (2007) Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets. Bosn J Basic Med Sci 7:328–334

    PubMed  Google Scholar 

  • Zaid AN, Ghosh AA (2011) Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements. Arch Pharm Res 34:1183–1189

    Article  PubMed  CAS  Google Scholar 

  • Zaid AN, Abu Ghosh A, Kittana N (2010) Weight uniformity of scored tablet halves manufactured by Palestinian pharmaceutical companies. Intern J Pharm Compd 14:257–260

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdel Naser Zaid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaid, A.N., Al-Ramahi, R., Ghoush, A.A. et al. Influence of physical factors on tablet splitting, weight and content uniformity of atenolol tablets. Journal of Pharmaceutical Investigation 42, 229–234 (2012). https://doi.org/10.1007/s40005-012-0030-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-012-0030-7

Keywords

Navigation